BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 30140160)

  • 1. Right- and left-sided stage III colon cancers present different prognostic outcomes of oxaliplatin-based adjuvant chemotherapy after curative resection.
    Peng J; Li C; Wang F; Zhang H; Xiao W; Li H; Lu Z; Pan Z; Wu X; Zhang R
    Cancer Manag Res; 2018; 10():2095-2103. PubMed ID: 30140160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer.
    Peng J; Zhang R; Zhao Y; Wu X; Chen G; Wan D; Lu Z; Pan Z
    Chin J Cancer; 2017 Dec; 36(1):96. PubMed ID: 29268783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of oncological outcomes of right-sided colon cancer versus left-sided colon cancer after curative resection: Which side is better outcome?
    Lim DR; Kuk JK; Kim T; Shin EJ
    Medicine (Baltimore); 2017 Oct; 96(42):e8241. PubMed ID: 29049212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of chemotherapy, primary tumor location and histological subtype on the survival of stage III colon cancer patients.
    Zhou C; Lu L; Huang Q; Tang Z; Tang R; Xiao Z; Xiao S
    BMC Gastroenterol; 2023 Apr; 23(1):110. PubMed ID: 37020295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor location impact in stage II and III colon cancer: epidemiological and outcome evaluation.
    Mejri N; Dridi M; El Benna H; Labidi S; Daoud N; Boussen H
    J Gastrointest Oncol; 2018 Apr; 9(2):263-268. PubMed ID: 29755764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Female Sex and Right-Sided Tumor Location Are Poor Prognostic Factors for Patients With Stage III Colon Cancer After a Curative Resection.
    Park JH; Park HC; Park SC; Oh JH; Kim DW; Kang SB; Heo SC; Kim MJ; Park JW; Jeong SY; Park KJ
    Ann Coloproctol; 2018 Dec; 34(6):286-291. PubMed ID: 30630302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncological impact of vascular invasion in colon cancer might differ depending on tumor sidedness.
    Shalkamy MSA; Bae JH; Lee CS; Han SR; Kim JH; Kye BH; Lee IK; Lee YS
    J Minim Invasive Surg; 2022 Jun; 25(2):53-62. PubMed ID: 35821690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of right-sided and left-sided colon cancer after curative resection.
    Yang CY; Yen MH; Kiu KT; Chen YT; Chang TC
    Sci Rep; 2022 Jul; 12(1):11323. PubMed ID: 35790871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
    Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With RAS and BRAF Mutational Status.
    Taieb J; Kourie HR; Emile JF; Le Malicot K; Balogoun R; Tabernero J; Mini E; Folprecht G; Van Laethem JL; Mulot C; Bouché O; Aparicio T; Michel P; Thaler J; Bridgewater J; Van Cutsem E; Perkins G; Lepage C; Salazar R; Laurent-Puig P;
    JAMA Oncol; 2018 Jul; 4(7):e173695. PubMed ID: 29167892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 627 patients with right- and left-sided colon cancer in China: Differences in clinicopathology, recurrence, and survival.
    Qin Q; Yang L; Sun YK; Ying JM; Song Y; Zhang W; Wang JW; Zhou AP
    Chronic Dis Transl Med; 2017 Mar; 3(1):51-59. PubMed ID: 29063056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of a modified XELOX adjuvant regimen for patients with operated stage III colon cancer: a Chinese single-center experience.
    Peng J; Li W; Zhang R; Lin J; Tang J; Wen Y; Lu Z; Wu X; Pan Z
    Cancer Commun (Lond); 2019 Oct; 39(1):59. PubMed ID: 31619288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological differences and correlations between right and left colon cancer.
    Kalantzis I; Nonni A; Pavlakis K; Delicha EM; Miltiadou K; Kosmas C; Ziras N; Gkoumas K; Gakiopoulou H
    World J Clin Cases; 2020 Apr; 8(8):1424-1443. PubMed ID: 32368535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive recurrences determine oncologic outcomes after resection of liver metastases from primary right colon cancer: Results of a case-control study.
    Zimmitti G; Panettieri E; Ardito F; Mele C; Maria V; Rosso E; Nuzzo G; Giuliante F
    Eur J Surg Oncol; 2021 Apr; 47(4):834-841. PubMed ID: 33032866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical baseline and prognostic difference of platelet lymphocyte ratio (PLR) in right-sided and let-sided colon cancers.
    Yang L; He W; Kong P; Jiang C; Yang Q; Xie Q; Xia LP
    BMC Cancer; 2017 Dec; 17(1):873. PubMed ID: 29262803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of primary tumor location and mismatch repair status guides adjuvant chemotherapy in stage II colon cancer.
    Yang L; He W; Yang Q; Kong P; Xie Q; Jiang C; Zhang B; Xia LP
    Oncotarget; 2017 Nov; 8(58):99136-99149. PubMed ID: 29228759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Factors and Differences in Survival of Right and Left Colon Carcinoma: A STROBE Compliant Retrospective Cohort Study.
    Beltrán L; González-Trejo S; Carmona-Herrera DD; Carrillo JF; Herrera-Goepfert R; Aiello-Crocifoglio V; Gallardo-Rincón D; Meléndez-Ponce NA; Ochoa-Carrillo FJ; Oñate-Ocaña LF
    Arch Med Res; 2019 Feb; 50(2):63-70. PubMed ID: 31349955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Worse Prognosis of Right-Sided Compared with Left-Sided Colon Cancers: a Systematic Review and Meta-analysis.
    Yahagi M; Okabayashi K; Hasegawa H; Tsuruta M; Kitagawa Y
    J Gastrointest Surg; 2016 Mar; 20(3):648-55. PubMed ID: 26573851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the Different Locations of Colon Cancer Affect the Oncologic Outcome? A Propensity-Score Matched Analysis.
    Yang KM; Park IJ; Lee JL; Yoon YS; Kim CW; Lim SB; Kim NY; Hong S; Yu CS; Kim JC
    Ann Coloproctol; 2019 Feb; 35(1):15-23. PubMed ID: 30879280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in oncological outcomes and inflammatory biomarkers between right-sided and left-sided stage I-III colorectal adenocarcinoma.
    Guo D; Li X; Xie A; Cao Q; Zhang J; Zhang F; Li W; Chen J
    J Clin Lab Anal; 2020 Apr; 34(4):e23132. PubMed ID: 31755593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.